dc.creatorRudzinski, Marcelo
dc.creatorPardini, Lais Luján
dc.creatorBernstein, Mariana
dc.creatorMoré, Gastón Andrés
dc.creatorKhoury, Marina
dc.creatorDuarte, Silvana Carolina
dc.creatorArgüelles, Carina Francisca
dc.creatorReina, Silvia
dc.creatorOubiña, Jose Raul
dc.date2020-09
dc.date2022-11-16T17:18:46Z
dc.date.accessioned2023-07-15T05:03:37Z
dc.date.available2023-07-15T05:03:37Z
dc.identifierhttp://sedici.unlp.edu.ar/handle/10915/145951
dc.identifierissn:1476-1645
dc.identifierissn:0002-9637
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7471932
dc.descriptionPeripheral blood mononuclear cells (PBMC) from patients with ocular toxoplasmosis were challenged with total antigens from Toxoplasma gondii lysate (TATL) in a cytokine release assay (CRA), run during the inactive period of the disease. Increased interferon gamma (IFN-γ) levels were detected after PBMC stimulation with either ME49 reference strain (P = 0.0015) or local TgCkAr-11-9 isolate (P = 0.0012), as compared with those recorded under basal conditions. TATL from TgCkAr11-9 isolate induced a higher release of IFN-γ than ME49 strain in CRA from all tested patients (P = 0.02). The median value of IFN-γ release on TgCkAr-11-9 stimulation (26.03 pg/mL) allowed the classification of patients into high- or low-/non-IFN-γ releasers. Clinical correlations were established with both groups. The results obtained in this study suggest the need to include local strains when performing CRA with TATL.
dc.descriptionFacultad de Ciencias Veterinarias
dc.formatapplication/pdf
dc.format2239-2243
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightsCreative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
dc.subjectBiología
dc.subjectCiencias Médicas
dc.subjectOcular toxoplasmosis
dc.subjectCytokine release
dc.titleInterferon-γ and IL-10 release assay for patients with ocular toxoplasmosis
dc.typeArticulo
dc.typeArticulo


Este ítem pertenece a la siguiente institución